CHM chimeric therapeutics limited

Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-37

  1. 1,346 Posts.
    lightbulb Created with Sketch. 231
    Good luck with your investment journey.

    With the recent positive announcements from each company (RAC, IMU, CHM) and after getting "comfortable" with each company, CHM stands out as the most compelling.

    * Very low MC
    * Very good results that are streamlined to treating SPECIFIC cancers
    * Small team
    * I feel Jen Chow has really proven herself as a mover and shaker. I feel that the last acquisition from IMU was mostly due to her.

    I for one really believe out of IMU, RAC and CHM, that CHM is the superior investment.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.33K 3.775M

Buyers (Bids)

No. Vol. Price($)
75 71644408 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 87927011 26
View Market Depth
Last trade - 14.48pm 31/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.